Hospital Universitario La Paz-ko ikertzaileekin lankidetzan egindako argitalpenak (11)

2022

  1. Further validation and psychometric properties of the Spanish adaptation of the Genetic Counseling Outcome Scale

    Journal of Genetic Counseling, Vol. 31, Núm. 1, pp. 71-81

2009

  1. Combination therapy with docetaxel and low dose of cisplatin in elderly patients with advanced non-small cell lung cancer: Multicenter phase II study

    Cancer Chemotherapy and Pharmacology, Vol. 63, Núm. 3, pp. 403-409

2008

  1. Cardiac toxicity: Old and new issues in anti-cancer drugs

    Clinical and Translational Oncology, Vol. 10, Núm. 1, pp. 35-46

2007

  1. Immunogenicity and reactogenicity of primary immunization with a novel combined Haemophilus influenzae type b and Neisseria meningitidis serogroup C-tetanus toxoid conjugate vaccine coadministered with a diphtheria-tetanus- acellular pertussis-hepatitis B-inactivated poliovirus vaccine at 2, 4 and 6 months

    Pediatric Infectious Disease Journal, Vol. 26, Núm. 1, pp. 1-7

2006

  1. Docetaxel and mitomycin as second-line treatment in advanced non-small cell lung cancer

    Cancer Chemotherapy and Pharmacology, Vol. 58, Núm. 4, pp. 527-531

  2. Fixed dose-rate infusion of gemcitabine in combination with cisplatin and UFT in advanced carcinoma of the pancreas

    Cancer Chemotherapy and Pharmacology, Vol. 58, Núm. 4, pp. 419-426

  3. Immunogenicity and reactogenicity of primary immunization with a hexavalent diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated polio-Haemophilus influenzae type B vaccine coadministered with two doses of a meningococcal C-tetanus toxoid conjugate vaccine

    Pediatric Infectious Disease Journal, Vol. 25, Núm. 8, pp. 713-720

2003

  1. Combination of low-dose cisplatin and gemcitabine for treatment of elderly patients with advanced non-small-cell lung cancer

    Cancer Chemotherapy and Pharmacology, Vol. 52, Núm. 3, pp. 247-252

1999

  1. Gemcitabine plus vinorelbine in nonsmall cell lung carcinoma patients age 70 years or older or patients who cannot receive cisplatin

    Cancer, Vol. 86, Núm. 8, pp. 1463-1469

1998

  1. Tratamiento neoadyuvante del cancer de recto con UFT-acido folinico y radioterapia: Resultados preliminares

    Neoplasia, Vol. 15, Núm. 3, pp. 77-82

1996

  1. Treatment of metastatic malignant melanoma with cisplatin plus tamoxifen

    Cancer Chemotherapy and Pharmacology, Vol. 38, Núm. 2, pp. 191-194